SenesTech, Inc.

Equities

SNES

US81720R5054

Biotechnology & Medical Research

Delayed Nasdaq 10:55:38 2024-04-25 am EDT 5-day change 1st Jan Change
0.7011 USD -7.90% Intraday chart for SenesTech, Inc. +0.16% -44.80%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Certain Warrants of SenesTech, Inc. are subject to a Lock-Up Agreement Ending on 26-FEB-2024. CI
Certain Common Stock of SenesTech, Inc. are subject to a Lock-Up Agreement Ending on 26-FEB-2024. CI
Transcript : SenesTech, Inc., Q4 2023 Earnings Call, Feb 21, 2024
SenesTech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
SenesTech Taps Q-chem to Distribute Pest Control Product in Netherlands MT
SenesTech, Inc. Announces Exclusive Distribution Agreement with Q-Chem for Evolve Soft Bait in Netherlands CI
Senestech, Inc. Announces Exclusive Distribution Agreement for Evolve Soft Bait in Australia and New Zealand CI
SenesTech Signs Distribution Deal With Agro Technic MT
Senestech Announces Exclusive Distribution Agreement and Initial Order for Evolve? Soft Bait in Singapore CI
Senestech Signs Poppe Enterprises for Evolve? Distribution in Grain Management Market CI
SenesTech Partners with Global Leader in Irrigation Solutions to Expand Evolve Soft Bait to Open Field Agriculture Applications CI
Sector Update: Health Care Stocks Gain Late Afternoon MT
Sector Update: Health Care Stocks Rise Tuesday Afternoon MT
Top Midday Gainers MT
SenesTech Expands Distribution Deal With Pesterminators; Shares Rise MT
SenesTech, Inc. Announces the Expansion of Its Distribution Agreement with Pesterminators Pvt Ltd to Include the Deployment of Evolve CI
Top Premarket Gainers MT
SenesTech, Inc. Announces Exclusive Distribution Agreement and Initial Order for Evolve Soft Bait in Hong Kong and Macau CI
SenesTech's ContraPest Registered for Use in Puerto Rico to Combat Rat Infestations CI
SenesTech Closes $5 Million Public Offering MT
Top Midday Decliners MT
Traders Await Economic Data as US Equity Futures Post Narrow Losses Pre-Bell MT
Fed Officials Comments Awaited as Exchange-Traded Funds, Equity Futures Decline Pre-Bell Tuesday MT
Top Premarket Decliners MT
SenesTech Prices $5 Million Public Offering MT
Chart SenesTech, Inc.
More charts
SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company has two product lines of fertility control products: ContraPest and Evolve. Its product ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions of the rat population. ContraPest is a highly palatable liquid formulation that reduces fertility in both male and female rats. Additionally, ContraPest does not cause illness in rats, and, therefore, it does not change behavior or result in bait aversion. ContraPest offers a new tool used in coordination with rodenticides as part of an integrated pest management program. The Company's technology can also be applied to other mammalian species.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.7612 USD
Average target price
3.5 USD
Spread / Average Target
+359.80%
Consensus
  1. Stock Market
  2. Equities
  3. SNES Stock
  4. News SenesTech, Inc.
  5. Earnings Flash (SNES) SENESTECH Posts Q1 Revenue $195,000, vs. Street Est of $193,000